These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14164426)

  • 1. [OBSERVATIONS ON RENAL ACTIVITY OF THE SPIROLACTONES].
    FREZZA M
    Gazz Int Med Chir; 1963 Dec; 67():2495-501. PubMed ID: 14164426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our experiences with the aldosterone blocking agent, aldactone in obstetrics].
    STARK G
    Geburtshilfe Frauenheilkd; 1962 Feb; 22():155-61. PubMed ID: 13916310
    [No Abstract]   [Full Text] [Related]  

  • 3. [Observations on the effect of the aldosterone antagonist spironolactone (aldactone) in normal and toxemic pregnancy (preliminary report)].
    RICHTER RH; ARNOLD M
    Gynaecologia; 1961; 152():248-57. PubMed ID: 14492054
    [No Abstract]   [Full Text] [Related]  

  • 4. [1st observations on the use of spirolactones (synthetic anti-aldosterone steroids) in pregnancy nephropathies].
    MIGLIAVACCA A; BOMPIANI A
    Gynecol Obstet (Paris); 1961; 60():443-50. PubMed ID: 14473616
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of spirolactones on manifestations of experimental renal hypertension].
    KLEPPING J; CABANNE F; BRIET S; MICHIELS R
    J Med Lyon; 1962 Feb; 43():213-26. PubMed ID: 14456894
    [No Abstract]   [Full Text] [Related]  

  • 6. The blocking by spirolactones of the actions of aldosterone and cortisol upon the human kidney.
    MILLS JN; THOMAS S; WILLIAMSON KS
    J Endocrinol; 1962 Jan; 23():357-63. PubMed ID: 14474191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of refractory edema by spirolactones (antialdosterone). Clinical and biological study].
    VESIN P; BLANPIN O; JULIEN C; GIBOUDEAU J; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1959 Oct 9-23; 75():826-40. PubMed ID: 13841977
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE MODES OF RENAL ACTION OF ALDOSTERONE INHIBITORS. DEDUCTIONS CONCERNING THE POINTS OF ATTACK OF ALDOSTERONE AT THE LEVEL OF THE KIDNEY].
    ROMANI JD; BERNHEIM R; GOOSENS F
    Ann Endocrinol (Paris); 1963; 24():588-97. PubMed ID: 14051313
    [No Abstract]   [Full Text] [Related]  

  • 9. [DRUGS INHIBITING ALDOSTERONE SECRETION AND ALDOSTERONE ANTAGONISTS].
    TORIGAI T; FUKUCHI S; HANADA M; TAKAHASHI H; IDEMURA H; KUMAGAI T
    Sogo Rinsho; 1963 Oct; 12():1924-32. PubMed ID: 14092539
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spirolactones and edemas. New therapeutic and biologic studies].
    VESIN P; GIBOUDEAU ; DEBBASCH L; ETIENNE ; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1961 Apr 5-May 8; 77():522-31. PubMed ID: 13781050
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of antialdosterone compounds (spirolactones) on the antinatruresis of the upright position in pregnancy.
    LONGO LD; ASSALI NS
    Surg Gynecol Obstet; 1960 Jun; 110():673-5. PubMed ID: 14418164
    [No Abstract]   [Full Text] [Related]  

  • 12. THE INFLUENCE OF DIETARY SALT INTAKE ON PRE-ECLAMPSIA.
    BOWER D
    J Obstet Gynaecol Br Commonw; 1964 Feb; 71():123-5. PubMed ID: 14117226
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methods of treatment of edema. Classification of diuretics. Salidiuretics, corticoids, spirolactones].
    VESIN P
    Dia Med; 1961 Dec; 33():2962-75. PubMed ID: 13925635
    [No Abstract]   [Full Text] [Related]  

  • 14. THE MANAGEMENT OF ASCITES.
    SMITH AN; MCMANUS J
    Rev Surg; 1964; 21():1-16. PubMed ID: 14106700
    [No Abstract]   [Full Text] [Related]  

  • 15. [Introduction; spirolactones].
    TRAEGER J
    Lyon Med; 1961 May; 93():1023-7. PubMed ID: 13777813
    [No Abstract]   [Full Text] [Related]  

  • 16. THE TREATMENT OF CIRRHOTIC ASCITES.
    SHALDON S
    Acta Gastroenterol Belg; 1963; 26():558-71. PubMed ID: 14083742
    [No Abstract]   [Full Text] [Related]  

  • 17. [Edemas in cancer patients. Treatment with glucocorticoids and spirolactones].
    VESIN P; CATTAN R
    Bull Mem Soc Med Hop Paris; 1961 Apr 5-May 28; 77():532-6. PubMed ID: 13781049
    [No Abstract]   [Full Text] [Related]  

  • 18. Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology.
    Delyani JA
    Kidney Int; 2000 Apr; 57(4):1408-11. PubMed ID: 10760075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The hyperaldosteronism syndrome in edema caused by decompensated respiratory insufficiency and its treatment by spirolactones].
    BALMES A; VEDEL A; DAUVERCHAIN J; DUMAS A
    Poumon Coeur; 1962; 18():747-54. PubMed ID: 13966193
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
    Luther JM; Gainer JV; Murphey LJ; Yu C; Vaughan DE; Morrow JD; Brown NJ
    Hypertension; 2006 Dec; 48(6):1050-7. PubMed ID: 17043157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.